Pearson Correlation Between Clinical and Biochemical Variables With Serum F/E Ratio, Serum Cortisone, and Serum Cortisol in All of the Subjects Studied
. | Serum F/E Ratio . | Serum Cortisone . | Serum Cortisol . | |||
---|---|---|---|---|---|---|
Characteristics . | r . | P . | r . | P . | r . | P . |
Age | 0.12 | 0.16 | −0.30 | 0.0006a | −0.05 | 0.58 |
BMI, kg/m2 | 0.34 | 0.0001a | −0.24 | 0.007a | 0.16 | 0.08 |
Systolic BP, mm Hg | 0.39 | 0.0001a | −0.10 | 0.31 | 0.26 | 0.003a |
Diastolic BP, mm Hg | 0.25 | 0.005a | −0.18 | 0.04a | 0.14 | 0.11 |
SA, ng/dL | 0.03 | 0.67 | 0.16 | 0.08 | 0.11 | 0.22 |
PRA, ng/mL*h | −0.03 | 0.71 | 0.41 | 0.0001a | 0.16 | 0.06 |
Serum potassium, mEq/L | −0.24 | 0.007a | 0.15 | 0.08 | −0.14 | 0.12 |
MAC, mg/24 h | 0.23 | 0.01a | −0.07 | 0.44 | 0.10 | 0.29 |
FEK 24 h, % | 0.29 | 0.001a | −0.25 | 0.005a | −0.10 | 0.29 |
hs-CRP, mg/L | 0.24 | 0.008a | −0.15 | 0.09 | 0.10 | 0.29 |
PAI-1, µg/L | 0.08 | 0.40 | −0.08 | 0.38 | 0.03 | 0.75 |
TNF-α, ng/L | 0.26 | 0.004a | −0.18 | 0.05 | 0.08 | 0.38 |
IL-6, ng/L | −0.19 | 0.07 | 0.01 | 0.88 | −0.14 | 0.17 |
MMP9 activity, fold change | 0.08 | 0.39 | 0.04 | 0.69 | 0.10 | 0.34 |
MMP2 activity, fold change | 0.01 | 0.90 | 0.03 | 0.71 | 0.001 | 0.99 |
. | Serum F/E Ratio . | Serum Cortisone . | Serum Cortisol . | |||
---|---|---|---|---|---|---|
Characteristics . | r . | P . | r . | P . | r . | P . |
Age | 0.12 | 0.16 | −0.30 | 0.0006a | −0.05 | 0.58 |
BMI, kg/m2 | 0.34 | 0.0001a | −0.24 | 0.007a | 0.16 | 0.08 |
Systolic BP, mm Hg | 0.39 | 0.0001a | −0.10 | 0.31 | 0.26 | 0.003a |
Diastolic BP, mm Hg | 0.25 | 0.005a | −0.18 | 0.04a | 0.14 | 0.11 |
SA, ng/dL | 0.03 | 0.67 | 0.16 | 0.08 | 0.11 | 0.22 |
PRA, ng/mL*h | −0.03 | 0.71 | 0.41 | 0.0001a | 0.16 | 0.06 |
Serum potassium, mEq/L | −0.24 | 0.007a | 0.15 | 0.08 | −0.14 | 0.12 |
MAC, mg/24 h | 0.23 | 0.01a | −0.07 | 0.44 | 0.10 | 0.29 |
FEK 24 h, % | 0.29 | 0.001a | −0.25 | 0.005a | −0.10 | 0.29 |
hs-CRP, mg/L | 0.24 | 0.008a | −0.15 | 0.09 | 0.10 | 0.29 |
PAI-1, µg/L | 0.08 | 0.40 | −0.08 | 0.38 | 0.03 | 0.75 |
TNF-α, ng/L | 0.26 | 0.004a | −0.18 | 0.05 | 0.08 | 0.38 |
IL-6, ng/L | −0.19 | 0.07 | 0.01 | 0.88 | −0.14 | 0.17 |
MMP9 activity, fold change | 0.08 | 0.39 | 0.04 | 0.69 | 0.10 | 0.34 |
MMP2 activity, fold change | 0.01 | 0.90 | 0.03 | 0.71 | 0.001 | 0.99 |
Correlation was considered significant at the 0.05 level.
Pearson Correlation Between Clinical and Biochemical Variables With Serum F/E Ratio, Serum Cortisone, and Serum Cortisol in All of the Subjects Studied
. | Serum F/E Ratio . | Serum Cortisone . | Serum Cortisol . | |||
---|---|---|---|---|---|---|
Characteristics . | r . | P . | r . | P . | r . | P . |
Age | 0.12 | 0.16 | −0.30 | 0.0006a | −0.05 | 0.58 |
BMI, kg/m2 | 0.34 | 0.0001a | −0.24 | 0.007a | 0.16 | 0.08 |
Systolic BP, mm Hg | 0.39 | 0.0001a | −0.10 | 0.31 | 0.26 | 0.003a |
Diastolic BP, mm Hg | 0.25 | 0.005a | −0.18 | 0.04a | 0.14 | 0.11 |
SA, ng/dL | 0.03 | 0.67 | 0.16 | 0.08 | 0.11 | 0.22 |
PRA, ng/mL*h | −0.03 | 0.71 | 0.41 | 0.0001a | 0.16 | 0.06 |
Serum potassium, mEq/L | −0.24 | 0.007a | 0.15 | 0.08 | −0.14 | 0.12 |
MAC, mg/24 h | 0.23 | 0.01a | −0.07 | 0.44 | 0.10 | 0.29 |
FEK 24 h, % | 0.29 | 0.001a | −0.25 | 0.005a | −0.10 | 0.29 |
hs-CRP, mg/L | 0.24 | 0.008a | −0.15 | 0.09 | 0.10 | 0.29 |
PAI-1, µg/L | 0.08 | 0.40 | −0.08 | 0.38 | 0.03 | 0.75 |
TNF-α, ng/L | 0.26 | 0.004a | −0.18 | 0.05 | 0.08 | 0.38 |
IL-6, ng/L | −0.19 | 0.07 | 0.01 | 0.88 | −0.14 | 0.17 |
MMP9 activity, fold change | 0.08 | 0.39 | 0.04 | 0.69 | 0.10 | 0.34 |
MMP2 activity, fold change | 0.01 | 0.90 | 0.03 | 0.71 | 0.001 | 0.99 |
. | Serum F/E Ratio . | Serum Cortisone . | Serum Cortisol . | |||
---|---|---|---|---|---|---|
Characteristics . | r . | P . | r . | P . | r . | P . |
Age | 0.12 | 0.16 | −0.30 | 0.0006a | −0.05 | 0.58 |
BMI, kg/m2 | 0.34 | 0.0001a | −0.24 | 0.007a | 0.16 | 0.08 |
Systolic BP, mm Hg | 0.39 | 0.0001a | −0.10 | 0.31 | 0.26 | 0.003a |
Diastolic BP, mm Hg | 0.25 | 0.005a | −0.18 | 0.04a | 0.14 | 0.11 |
SA, ng/dL | 0.03 | 0.67 | 0.16 | 0.08 | 0.11 | 0.22 |
PRA, ng/mL*h | −0.03 | 0.71 | 0.41 | 0.0001a | 0.16 | 0.06 |
Serum potassium, mEq/L | −0.24 | 0.007a | 0.15 | 0.08 | −0.14 | 0.12 |
MAC, mg/24 h | 0.23 | 0.01a | −0.07 | 0.44 | 0.10 | 0.29 |
FEK 24 h, % | 0.29 | 0.001a | −0.25 | 0.005a | −0.10 | 0.29 |
hs-CRP, mg/L | 0.24 | 0.008a | −0.15 | 0.09 | 0.10 | 0.29 |
PAI-1, µg/L | 0.08 | 0.40 | −0.08 | 0.38 | 0.03 | 0.75 |
TNF-α, ng/L | 0.26 | 0.004a | −0.18 | 0.05 | 0.08 | 0.38 |
IL-6, ng/L | −0.19 | 0.07 | 0.01 | 0.88 | −0.14 | 0.17 |
MMP9 activity, fold change | 0.08 | 0.39 | 0.04 | 0.69 | 0.10 | 0.34 |
MMP2 activity, fold change | 0.01 | 0.90 | 0.03 | 0.71 | 0.001 | 0.99 |
Correlation was considered significant at the 0.05 level.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.